Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Methotrexate in Active Vitiligo
NCT04942860Phase 3Completed
- Sponsor
- Nicolaus Copernicus University
- Start
- Oct 2019
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of methotrexate in Vitiligo, sponsored by Nicolaus Copernicus University. Primary endpoint: Repigmentation of vitiligous lesions at 12 weeks. Started Oct 2019; status: completed.
02
Drugs
methotrexate
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT04942860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04942860.